A citation-based method for searching scientific literature

Line Skute Bråten, Tore Haslemo, Marin M Jukic, Maxim Ivanov, Magnus Ingelman-Sundberg, Espen Molden, Marianne Kristiansen Kringen. Clin Pharmacol Ther 2021
Times Cited: 16







List of co-cited articles
72 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients.
Marin M Jukić, Tore Haslemo, Espen Molden, Magnus Ingelman-Sundberg. Am J Psychiatry 2018
87
50

Integrating rare genetic variants into pharmacogenetic drug response predictions.
Magnus Ingelman-Sundberg, Souren Mkrtchian, Yitian Zhou, Volker M Lauschke. Hum Genomics 2018
105
37

Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update.
J K Hicks, K Sangkuhl, J J Swen, V L Ellingrod, D J Müller, K Shimoda, J R Bishop, E D Kharasch, T C Skaar, A Gaedigk,[...]. Clin Pharmacol Ther 2017
296
37

Identification of a novel polymorphism associated with reduced clozapine concentration in schizophrenia patients-a genome-wide association study adjusting for smoking habits.
Robert Løvsletten Smith, Kevin O'Connell, Lavinia Athanasiu, Srdjan Djurovic, Marianne Kristiansen Kringen, Ole A Andreassen, Espen Molden. Transl Psychiatry 2020
17
31

The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients.
Hasan Çağın Lenk, Katharina Klöditz, Inger Johansson, Robert Løvsletten Smith, Marin M Jukić, Espen Molden, Magnus Ingelman-Sundberg. Clin Pharmacol Ther 2022
7
71


Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
Volker M Lauschke, Lili Milani, Magnus Ingelman-Sundberg. AAPS J 2017
78
25


Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study.
Marin M Jukic, Robert L Smith, Tore Haslemo, Espen Molden, Magnus Ingelman-Sundberg. Lancet Psychiatry 2019
62
25

Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure: A Systematic Review and Meta-analysis.
Filip Milosavljevic, Nikola Bukvic, Zorana Pavlovic, Cedo Miljevic, Vesna Pešic, Espen Molden, Magnus Ingelman-Sundberg, Stefan Leucht, Marin M Jukic. JAMA Psychiatry 2021
36
25

Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements.
Rawan Shekhani, Linda Steinacher, Jesse J Swen, Magnus Ingelman-Sundberg. Clin Pharmacol Ther 2020
35
25

Heritability of metoprolol and torsemide pharmacokinetics.
J Matthaei, J Brockmöller, M V Tzvetkov, D Sehrt, C Sachse-Seeboth, J B Hjelmborg, S Möller, U Halekoh, U Hofmann, M Schwab,[...]. Clin Pharmacol Ther 2015
41
25

Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data.
Maaike van der Lee, William G Allard, Rolf H A M Vossen, Renée F Baak-Pablo, Roberta Menafra, Birgit A L M Deiman, Maarten J Deenen, Patrick Neven, Inger Johansson, Stefano Gastaldello,[...]. Sci Transl Med 2021
19
25

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
18


PharmVar GeneFocus: CYP2B6.
Zeruesenay Desta, Ahmed El-Boraie, Li Gong, Andrew A Somogyi, Volker M Lauschke, Collet Dandara, Kathrin Klein, Neil A Miller, Teri E Klein, Rachel F Tyndale,[...]. Clin Pharmacol Ther 2021
19
18

Ethnogeographic and inter-individual variability of human ABC transporters.
Qingyang Xiao, Yitian Zhou, Volker M Lauschke. Hum Genet 2020
28
18


PharmVar GeneFocus: CYP2C19.
Mariana R Botton, Michelle Whirl-Carrillo, Andria L Del Tredici, Katrin Sangkuhl, Larisa H Cavallari, José A G Agúndez, Jorge Duconge, Ming Ta Michael Lee, Erica L Woodahl, Karla Claudio-Campos,[...]. Clin Pharmacol Ther 2021
33
18

Pharmacogenetics at Scale: An Analysis of the UK Biobank.
Gregory McInnes, Adam Lavertu, Katrin Sangkuhl, Teri E Klein, Michelle Whirl-Carrillo, Russ B Altman. Clin Pharmacol Ther 2021
38
18

Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates.
Marin M Jukić, Robert L Smith, Espen Molden, Magnus Ingelman-Sundberg. Clin Pharmacol Ther 2021
13
23

Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Yitian Zhou, Gabriel Herras Arribas, Ainoleena Turku, Tuuli Jürgenson, Souren Mkrtchian, Kristi Krebs, Yi Wang, Barbora Svobodova, Lili Milani, Gunnar Schulte,[...]. Sci Adv 2021
8
37

An Evidence-Based Framework for Evaluating Pharmacogenomics Knowledge for Personalized Medicine.
Michelle Whirl-Carrillo, Rachel Huddart, Li Gong, Katrin Sangkuhl, Caroline F Thorn, Ryan Whaley, Teri E Klein. Clin Pharmacol Ther 2021
106
18


A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.
Sarah C Sim, Carl Risinger, Marja-Liisa Dahl, Eleni Aklillu, Magnus Christensen, Leif Bertilsson, Magnus Ingelman-Sundberg. Clin Pharmacol Ther 2006
535
18

Genetic differences in cytochrome P450 enzymes and antidepressant treatment response.
Karen Hodgson, Katherine Tansey, Mojca Zvezdana Dernovsek, Joanna Hauser, Neven Henigsberg, Wolfgang Maier, Ole Mors, Anna Placentino, Marcella Rietschel, Daniel Souery,[...]. J Psychopharmacol 2014
52
18

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.
Line S Bråten, Tore Haslemo, Marin M Jukic, Magnus Ingelman-Sundberg, Espen Molden, Marianne K Kringen. Neuropsychopharmacology 2020
17
18

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.
C Hiemke, N Bergemann, H W Clement, A Conca, J Deckert, K Domschke, G Eckermann, K Egberts, M Gerlach, C Greiner,[...]. Pharmacopsychiatry 2018
445
18

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
J K Hicks, J R Bishop, K Sangkuhl, D J Müller, Y Ji, S G Leckband, J S Leeder, R L Graham, D L Chiulli, A LLerena,[...]. Clin Pharmacol Ther 2015
535
18

The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity.
Dominik G Grimm, Chloé-Agathe Azencott, Fabian Aicheler, Udo Gieraths, Daniel G MacArthur, Kaitlin E Samocha, David N Cooper, Peter D Stenson, Mark J Daly, Jordan W Smoller,[...]. Hum Mutat 2015
183
12

Computational Methods for the Pharmacogenetic Interpretation of Next Generation Sequencing Data.
Yitian Zhou, Kohei Fujikura, Souren Mkrtchian, Volker M Lauschke. Front Pharmacol 2018
42
12

Transfer learning enables prediction of CYP2D6 haplotype function.
Gregory McInnes, Rachel Dalton, Katrin Sangkuhl, Michelle Whirl-Carrillo, Seung-Been Lee, Philip S Tsao, Andrea Gaedigk, Russ B Altman, Erica L Woodahl. PLoS Comput Biol 2020
18
12

PharmVar GeneFocus: CYP2D6.
Charity Nofziger, Amy J Turner, Katrin Sangkuhl, Michelle Whirl-Carrillo, José A G Agúndez, John L Black, Henry M Dunnenberger, Gualberto Ruano, Martin A Kennedy, Michael S Phillips,[...]. Clin Pharmacol Ther 2020
101
12


Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.
María Santos, Mikko Niemi, Masahiro Hiratsuka, Masaki Kumondai, Magnus Ingelman-Sundberg, Volker M Lauschke, Cristina Rodríguez-Antona. Genet Med 2018
52
12


An optimized prediction framework to assess the functional impact of pharmacogenetic variants.
Yitian Zhou, Souren Mkrtchian, Masaki Kumondai, Masahiro Hiratsuka, Volker M Lauschke. Pharmacogenomics J 2019
67
12

Gene-Specific Variant Classifier (DPYD-Varifier) to Identify Deleterious Alleles of Dihydropyrimidine Dehydrogenase.
Shikshya Shrestha, Cheng Zhang, Calvin R Jerde, Qian Nie, Hu Li, Steven M Offer, Robert B Diasio. Clin Pharmacol Ther 2018
30
12

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant.
Matthew G McDonald, Mark J Rieder, Mariko Nakano, Clara K Hsia, Allan E Rettie. Mol Pharmacol 2009
221
12

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics-Guided Warfarin Dosing: 2017 Update.
J A Johnson, K E Caudle, L Gong, M Whirl-Carrillo, C M Stein, S A Scott, M T Lee, B F Gage, S E Kimmel, M A Perera,[...]. Clin Pharmacol Ther 2017
309
12

Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines.
Heshu Abdullah-Koolmees, Antonius M van Keulen, Marga Nijenhuis, Vera H M Deneer. Front Pharmacol 2021
39
12

Economic evaluation in psychiatric pharmacogenomics: a systematic review.
Kariofyllis Karamperis, Maria Koromina, Panagiotis Papantoniou, Maria Skokou, Filippos Kanellakis, Konstantinos Mitropoulos, Athanassios Vozikis, Daniel J Müller, George P Patrinos, Christina Mitropoulou. Pharmacogenomics J 2021
11
18

Genomewide Association Studies in Pharmacogenomics.
Gregory McInnes, Sook Wah Yee, Yash Pershad, Russ B Altman. Clin Pharmacol Ther 2021
11
18

The transcription factor gene Nfib is essential for both lung maturation and brain development.
George Steele-Perkins, Céline Plachez, Kenneth G Butz, Guanhu Yang, Cindy J Bachurski, Stephen L Kinsman, E David Litwack, Linda J Richards, Richard M Gronostajski. Mol Cell Biol 2005
215
12

NFIB promotes the progression of gastric cancer by upregulating circMAP7D1 to stabilize HER2 mRNA.
Huimin Yang, Zhengzhen Wu, Xin Liu, Min Chen, Xin Zhang, Yong Jiang. Mol Med Rep 2021
7
28

Genome-Wide Approach to Measure Variant-Based Heritability of Drug Outcome Phenotypes.
Ayesha Muhammad, Ida T Aka, Kelly A Birdwell, Adam S Gordon, Dan M Roden, Wei-Qi Wei, Jonathan D Mosley, Sara L Van Driest. Clin Pharmacol Ther 2021
4
50

Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.
Miriam Saiz-Rodríguez, Carmen Belmonte, Manuel Román, Dolores Ochoa, Dora Koller, María Talegón, María C Ovejero-Benito, Rosario López-Rodríguez, Teresa Cabaleiro, Francisco Abad-Santos. Basic Clin Pharmacol Toxicol 2018
33
12

Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression--The EMC trial.
André Tadić, Daniel Wachtlin, Mathias Berger, Dieter F Braus, Dietrich van Calker, Norbert Dahmen, Nadine Dreimüller, Alice Engel, Stanislav Gorbulev, Isabella Helmreich,[...]. Eur Neuropsychopharmacol 2016
31
12

Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Andrea Cipriani, Toshi A Furukawa, Georgia Salanti, Anna Chaimani, Lauren Z Atkinson, Yusuke Ogawa, Stefan Leucht, Henricus G Ruhe, Erick H Turner, Julian P T Higgins,[...]. Lancet 2018
12

Metabolomics reveals biomarkers in human urine and plasma to predict cytochrome P450 2D6 (CYP2D6) activity.
Gaëlle Magliocco, Jules Desmeules, Alain Matthey, Luis M Quirós-Guerrero, Nasim Bararpour, Timothée Joye, Laurence Marcourt, Emerson F Queiroz, Jean-Luc Wolfender, Yvonne Gloor,[...]. Br J Pharmacol 2021
10
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.